Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 65.44B | 63.61B | 64.88B | 58.79B | 45.21B |
Gross Profit | 5.96B | 7.17B | 6.39B | 4.37B | 4.33B |
EBITDA | 3.43B | 5.78B | 3.98B | 2.63B | 2.96B |
Net Income | 624.90M | 2.70B | 1.51B | 702.95M | 1.39B |
Balance Sheet | |||||
Total Assets | 46.05B | 48.01B | 46.36B | 42.75B | 34.73B |
Cash, Cash Equivalents and Short-Term Investments | 4.39B | 3.19B | 2.84B | 1.96B | 2.19B |
Total Debt | 13.50B | 15.72B | 17.04B | 16.00B | 10.00B |
Total Liabilities | 21.47B | 23.69B | 25.25B | 23.48B | 16.79B |
Stockholders Equity | 24.54B | 24.29B | 21.09B | 19.26B | 17.92B |
Cash Flow | |||||
Free Cash Flow | 3.91B | 1.34B | -63.61M | -6.29B | -1.40B |
Operating Cash Flow | 5.60B | 3.22B | 4.91B | -4.75B | 153.83M |
Investing Cash Flow | -1.46B | -1.96B | -4.98B | -1.36B | -1.49B |
Financing Cash Flow | -2.72B | -1.63B | 890.99M | 5.70B | 1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥6.26B | 18.71 | 5.72% | 3.76% | -84.33% | ||
73 Outperform | ¥7.40B | 15.85 | ― | 15.58% | ― | ||
71 Outperform | ¥6.44B | 12.97 | 2.63% | 13.34% | -74.02% | ||
69 Neutral | ¥5.16B | 8.95 | 3.04% | 5.61% | 7.09% | ||
68 Neutral | ¥6.61B | 4.83 | 2.53% | 1.49% | -54.66% | ||
62 Neutral | £500.82M | 27.12 | 0.85% | 2.82% | 3.88% | -21.07% | |
47 Neutral | ¥4.63B | ― | 2.01% | -21.49% | -155.24% |